Bausch Health ehemals VALEANT PHARMA Allergan-Übernahme beflügelt (Seite 19)
eröffnet am 30.04.14 17:10:46 von
neuester Beitrag 10.04.24 21:16:45 von
neuester Beitrag 10.04.24 21:16:45 von
Beiträge: 4.274
ID: 1.193.944
ID: 1.193.944
Aufrufe heute: 5
Gesamt: 390.001
Gesamt: 390.001
Aktive User: 0
ISIN: CA0717341071 · WKN: A2JQ1X · Symbol: BVF
6,5470
EUR
+1,02 %
+0,0660 EUR
Letzter Kurs 14:50:34 Tradegate
Neuigkeiten
09.05.24 · Accesswire  |
02.05.24 · Accesswire |
25.04.24 · wO Chartvergleich |
11.04.24 · Accesswire |
11.04.24 · Accesswire |
Werte aus der Branche Pharmaindustrie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 0,5700 | +55,23 | |
| 5,4500 | +41,56 | |
| 141,00 | +41,00 | |
| 150,47 | +38,68 | |
| 1,0000 | +33,33 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 0,7300 | -19,34 | |
| 20,000 | -20,00 | |
| 19,000 | -20,17 | |
| 18,280 | -21,55 | |
| 1,5100 | -24,12 |
Beitrag zu dieser Diskussion schreiben
Feedback
Antwort auf Beitrag Nr.: 63.835.916 von ODI01 am 28.05.20 20:08:05
Zitat von ODI01: https://seekingalpha.com/article/4350507-tracking-jeffrey-ubbens-valueact-portfolio-q1-2020-update?_v=1&color=1&hl=en&sp=1&theme=2
Bausch + Lomb Announces The European Launch Of LuxSmart™ And LuxGood™ Preloaded Intraocular Lenses
https://www.bauschhealth.com/news-room/news-releases/news-de…
https://otp.investis.com/generic/sec/sec-show.aspx?Cik=00008…
Senior Notes Offering
On May 26, 2020, Bausch Health Companies Inc. (the “Company”) completed its previously announced offering of $1,500,000,000 aggregate principal amount of its 6.250% Senior Notes due 2029 (the “Notes”).
The Notes were offered in the United States and sold to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and outside the United States to non-U.S. persons pursuant to Regulation S under the Securities Act. The Notes have not been and will not be registered under the Securities Act or any state securities law and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements.
The proceeds of the Notes offering, along with cash on hand, will be used to (i) fund the Company’s previously announced redemption of its existing 6.500% Senior Secured Notes due 2022, (ii) fund the prepayment of the mandatory amortization for 2022 under the Company’s existing term loans and (iii) pay related fees, premiums and expenses.
Senior Notes Offering
On May 26, 2020, Bausch Health Companies Inc. (the “Company”) completed its previously announced offering of $1,500,000,000 aggregate principal amount of its 6.250% Senior Notes due 2029 (the “Notes”).
The Notes were offered in the United States and sold to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and outside the United States to non-U.S. persons pursuant to Regulation S under the Securities Act. The Notes have not been and will not be registered under the Securities Act or any state securities law and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements.
The proceeds of the Notes offering, along with cash on hand, will be used to (i) fund the Company’s previously announced redemption of its existing 6.500% Senior Secured Notes due 2022, (ii) fund the prepayment of the mandatory amortization for 2022 under the Company’s existing term loans and (iii) pay related fees, premiums and expenses.
Mehr Darmkrebs durch Corona
https://www.welt.de/gesundheit/plus208204177/Wegen-Corona-ge…Kein Wunder, daß die VK Zahlen für Plenvue eingebrochen waren.
Trading Spotlight
Bausch Health To Participate At Goldman Sachs Annual Global Healthcare Conference
https://www.bauschhealth.com/news-room/news-releases/news-de…
Durchsuchen
25.04.24 · wO Chartvergleich · BAVARIA Industries Group Akt |
04.03.24 · wO Chartvergleich · Myriad Genetics |